• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于甲氨蝶呤中毒的活性炭血液灌流:当无法获得羧肽酶时一种安全有效的挽救生命的替代方法。

Charcoal Hemoperfusion for Methotrexate Toxicity: A Safe and Effective Life-Rescue Alternative When Glucarpidase Is Not Available.

作者信息

Rosales Alejandra, Madrid Alvaro, Muñoz Marina, Dapena Jose Luis, Ariceta Gema

机构信息

Department of Pediatrics, Medical University Innsbruck, Innsbruck, Austria.

Pediatric Nephrology, University Hospital Sant Joan de Deu, University of Barcelona, Barcelona, Spain.

出版信息

Front Pediatr. 2021 Aug 19;9:635152. doi: 10.3389/fped.2021.635152. eCollection 2021.

DOI:10.3389/fped.2021.635152
PMID:34490152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8417363/
Abstract

High dose methotrexate (HDMTX) is used for the treatment of pediatric hemato-oncological diseases. HDMTX can induce acute kidney injury in cases of delayed elimination. The use of leucovorin remains the most effective rescue action. Further treatment options are of difficult access in the rare cases where leucovorin fails to prevent renal failure from occurring. Glucarpidase is an effective treatment in cases of methotrexate (MTX) delayed elimination, but cost is high and availability is limited. Charcoal hemoperfusion (CHP) is a very efficient procedure to remove protein-bound drugs, promoting fast MTX elimination, but is rarely considered as a treatment option. We present three pediatric cases with prolonged exposure to MTX after HDMTX and delayed elimination in which hemoperfusion was performed as rescue treatment for methotrexate intoxication. Charcoal hemoperfusion was performed with positive results and no complications as bridging until glucarpidase was available in two cases and in one case where two doses of glucarpidase led to insufficient reduction of MTX levels. CHP can be considered as a rescue treatment option in MTX intoxication, since it is an effective and safe extracorporeal method for removing MTX, in cases where rescue with leucovorin is insufficient and glucarpidase is not available or while waiting for delivery.

摘要

大剂量甲氨蝶呤(HDMTX)用于治疗小儿血液肿瘤疾病。HDMTX在消除延迟的情况下可诱发急性肾损伤。使用亚叶酸钙仍然是最有效的解救措施。在亚叶酸钙未能预防肾衰竭发生的罕见情况下,进一步的治疗选择难以获得。羧肽酶G2在甲氨蝶呤(MTX)消除延迟的情况下是一种有效的治疗方法,但成本高且可用性有限。血液灌流(CHP)是一种非常有效的清除蛋白结合药物的方法,可促进MTX快速消除,但很少被视为一种治疗选择。我们报告了3例小儿患者,在HDMTX后MTX暴露时间延长且消除延迟,其中进行血液灌流作为甲氨蝶呤中毒的解救治疗。在2例患者中,血液灌流取得了阳性结果且无并发症,作为过渡措施直至羧肽酶G2可用;在1例患者中,两剂羧肽酶G2导致MTX水平降低不足。CHP可被视为MTX中毒的一种解救治疗选择,因为在亚叶酸钙解救不足且羧肽酶G2不可用或等待其送达时,它是一种有效且安全的体外清除MTX的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b17f/8417363/84d26cc2b2c7/fped-09-635152-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b17f/8417363/84d26cc2b2c7/fped-09-635152-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b17f/8417363/84d26cc2b2c7/fped-09-635152-g0001.jpg

相似文献

1
Charcoal Hemoperfusion for Methotrexate Toxicity: A Safe and Effective Life-Rescue Alternative When Glucarpidase Is Not Available.用于甲氨蝶呤中毒的活性炭血液灌流:当无法获得羧肽酶时一种安全有效的挽救生命的替代方法。
Front Pediatr. 2021 Aug 19;9:635152. doi: 10.3389/fped.2021.635152. eCollection 2021.
2
Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome.甲氨蝶呤致肾功能障碍时用葡醛内酯、亚叶酸钙和胸苷解救:影响疗效的临床和药理学因素。
J Clin Oncol. 2010 Sep 1;28(25):3979-86. doi: 10.1200/JCO.2009.25.4540. Epub 2010 Aug 2.
3
Sequential use of hemoperfusion and single-pass albumin dialysis can safely reverse methotrexate nephrotoxicity.序贯使用血液灌流和单次通过白蛋白透析可安全逆转甲氨蝶呤肾毒性。
Pediatr Nephrol. 2016 Oct;31(10):1699-703. doi: 10.1007/s00467-016-3389-2. Epub 2016 Jun 22.
4
Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.半剂量葡醛内酯对急性肾损伤患者中毒性甲氨蝶呤水平的有效解救。
Cancer Chemother Pharmacol. 2022 Jan;89(1):41-48. doi: 10.1007/s00280-021-04361-8. Epub 2021 Oct 20.
5
The use of glucarpidase as a rescue therapy for high dose methotrexate toxicity - a review of pharmacological and clinical data.葡醛酸钠酶在大剂量甲氨蝶呤中毒时作为解救治疗的应用:药理学和临床数据的回顾。
Expert Opin Drug Metab Toxicol. 2023 Jul-Dec;19(11):741-750. doi: 10.1080/17425255.2023.2272593. Epub 2023 Nov 17.
6
Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance.高剂量甲氨蝶呤诱导的急性肾损伤和甲氨蝶呤清除延迟患者使用葡萄糖醛酸酶的共识指南。
Oncologist. 2018 Jan;23(1):52-61. doi: 10.1634/theoncologist.2017-0243. Epub 2017 Oct 27.
7
Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy.羧肽酶G2对接受大剂量甲氨蝶呤治疗后出现肾功能不全及甲氨蝶呤清除延迟的成年和老年癌症患者的干预作用。
Oncologist. 2007 Nov;12(11):1299-308. doi: 10.1634/theoncologist.12-11-1299.
8
A European consensus recommendation on the management of delayed methotrexate elimination: supportive measures, leucovorin rescue and glucarpidase treatment.欧洲关于甲氨蝶呤消除延迟管理的共识性建议:支持措施、亚叶酸钙解救及羧肽酶G2治疗。
J Cancer Res Clin Oncol. 2024 Oct 2;150(10):441. doi: 10.1007/s00432-024-05945-6.
9
Incidence and management of patients with methotrexate delayed elimination in the clinical practice: A Delphi study.临床实践中甲氨蝶呤延迟消除患者的发生率和处理方法:一项德尔菲研究。
J Oncol Pharm Pract. 2023 Jun;29(4):794-801. doi: 10.1177/10781552221079568. Epub 2022 Feb 11.
10
Glucarpidase for the treatment of life-threatening methotrexate overdose.用于治疗危及生命的甲氨蝶呤过量的羧肽酶G2。
Drugs Today (Barc). 2012 Nov;48(11):705-11. doi: 10.1358/dot.2012.48.11.1871575.

引用本文的文献

1
Expanding the potential therapeutic options of hemoperfusion in the era of improved sorbent biocompatibility.在吸附剂生物相容性改善的时代拓展血液灌流的潜在治疗选择。
Kidney Res Clin Pract. 2023 May;42(3):298-311. doi: 10.23876/j.krcp.22.223. Epub 2023 Mar 29.

本文引用的文献

1
MTXPK.org: A Clinical Decision Support Tool Evaluating High-Dose Methotrexate Pharmacokinetics to Inform Post-Infusion Care and Use of Glucarpidase.MTXPK.org:一种评估大剂量甲氨蝶呤药代动力学的临床决策支持工具,以指导输注后护理和使用粘醛醯谷氨酸。
Clin Pharmacol Ther. 2020 Sep;108(3):635-643. doi: 10.1002/cpt.1957. Epub 2020 Jul 18.
2
Anticancer Drug-Induced Acute Kidney Injury.抗癌药物所致急性肾损伤
Kidney Int Rep. 2017 Feb 16;2(4):504-514. doi: 10.1016/j.ekir.2017.02.008. eCollection 2017 Jul.
3
Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance.
高剂量甲氨蝶呤诱导的急性肾损伤和甲氨蝶呤清除延迟患者使用葡萄糖醛酸酶的共识指南。
Oncologist. 2018 Jan;23(1):52-61. doi: 10.1634/theoncologist.2017-0243. Epub 2017 Oct 27.
4
Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?甲氨蝶呤消除延迟:发生率、与抗酸药物的相互作用及临床后果?
Hematol Oncol. 2018 Apr;36(2):399-406. doi: 10.1002/hon.2479. Epub 2017 Oct 6.
5
Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma.欧洲协作组 EURO-LB02 临床试验在儿童和青少年淋巴母细胞淋巴瘤中的结果和结论。
Haematologica. 2017 Dec;102(12):2086-2096. doi: 10.3324/haematol.2015.139162. Epub 2017 Oct 5.
6
Availability and cost of extracorporeal treatments for poisonings and other emergency indications: a worldwide survey.中毒和其他紧急适应症的体外治疗的可及性和成本:一项全球调查。
Nephrol Dial Transplant. 2017 Apr 1;32(4):699-706. doi: 10.1093/ndt/gfw456.
7
Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia.大剂量甲氨蝶呤在儿童急性淋巴细胞白血病治疗中的延迟清除及羧肽酶G2的应用
Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26395. Epub 2016 Dec 14.
8
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.新诊断的高级别骨肉瘤术前化疗反应不佳患者中MAPIE与MAP的比较(EURAMOS-1):一项开放标签、国际、随机对照试验
Lancet Oncol. 2016 Oct;17(10):1396-1408. doi: 10.1016/S1470-2045(16)30214-5. Epub 2016 Aug 25.
9
Preventing and Managing Toxicities of High-Dose Methotrexate.预防和管理大剂量甲氨蝶呤的毒性反应
Oncologist. 2016 Dec;21(12):1471-1482. doi: 10.1634/theoncologist.2015-0164. Epub 2016 Aug 5.
10
Sequential use of hemoperfusion and single-pass albumin dialysis can safely reverse methotrexate nephrotoxicity.序贯使用血液灌流和单次通过白蛋白透析可安全逆转甲氨蝶呤肾毒性。
Pediatr Nephrol. 2016 Oct;31(10):1699-703. doi: 10.1007/s00467-016-3389-2. Epub 2016 Jun 22.